Standard Biotools (LAB) Non-Current Assets (2016 - 2025)
Standard Biotools (LAB) has disclosed Non-Current Assets for 16 consecutive years, with $46.0 million as the latest value for Q4 2025.
- Quarterly Non-Current Assets fell 6.76% to $46.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.0 million through Dec 2025, down 6.76% year-over-year, with the annual reading at $46.0 million for FY2025, 6.76% down from the prior year.
- Non-Current Assets for Q4 2025 was $46.0 million at Standard Biotools, down from $67.2 million in the prior quarter.
- The five-year high for Non-Current Assets was $235.6 million in Q1 2025, with the low at $46.0 million in Q4 2025.
- Average Non-Current Assets over 5 years is $158.7 million, with a median of $188.1 million recorded in 2022.
- The sharpest move saw Non-Current Assets surged 35.24% in 2024, then plummeted 77.73% in 2025.
- Over 5 years, Non-Current Assets stood at $203.1 million in 2021, then plummeted by 70.69% to $59.5 million in 2022, then decreased by 7.87% to $54.8 million in 2023, then dropped by 10.04% to $49.3 million in 2024, then fell by 6.76% to $46.0 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods came in at $46.0 million, $67.2 million, and $50.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.